|
| | Publication Year | Title | Author(s) |
| 281 | Jun-2017 | Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases | Parakh, Sagun ; Park, John J; Mendis, Shehara; Rai, Rajat; Xu, Wen; Lo, Serigne; Drummond, Martin; Rowe, Catherine; Wong, Annie; McArthur, Grant; Haydon, Andrew; Andrews, Miles C; Cebon, Jonathan S ; Guminski, Alex; Kefford, Richard F; Long, Georgina V; Menzies, Alexander M; Klein, Oliver ; Carlino, Matteo S |
| 282 | 15-Mar-2007 | The efficacy of epidermal growth factor receptor-specific antibodies against glioma xenografts is influenced by receptor levels, activation status, and heterodimerization. | Johns, Terrance G; Perera, Rushika M; Vernes, Sonja C; Vitali, Angela A; Cao, Diana; Cavenee, Webster K; Scott, Andrew M ; Furnari, Frank B |
| 283 | 2021 | Efficacy of mobile health cardiovascular risk-reduction strategies in cancer survivors. | Murphy, Alexandra C ; Koshy, Anoop N ; Mousley, Johanna; Meehan, Georgina; Kunniardy, Phelia ; Clark, David J ; Kearney, Leighton G ; Yeo, Belinda ; Farouque, Omar ; Yudi, Matias B |
| 284 | 6-Sep-2017 | EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma. | Clay, Timothy D; Russell, Prudence A; Do, Hongdo; Sundararajan, Vijaya; Conron, Matthew; Wright, Gavin M; Solomon, Benjamin; Dobrovic, Alexander ; McLachlan, Sue-Anne; Moore, Melissa M |
| 285 | Dec-2018 | EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer. | John, Thomas ; Akamatsu, Hiroaki; Delmonte, Angelo; Su, Wu-Chou; Lee, Jong Seok; Chang, Gee-Chen; Huang, Xiangning; Jenkins, Suzanne; Wu, Yi-Long |
| 286 | 10-Mar-2021 | EGFRvIII Promotes Cell Survival during Endoplasmic Reticulum Stress through a Reticulocalbin 1-Dependent Mechanism. | Gomez, Juliana; Areeb, Zammam; Stuart, Sarah F; Nguyen, Hong P T; Paradiso, Lucia; Zulkifli, Ahmad; Madan, Sonakshi; Rajagopal, Vijay; Montgomery, Magdalene K; Gan, Hui K ; Scott, Andrew M ; Jones, Jordan; Kaye, Andrew H; Morokoff, Andrew P; Luwor, Rodney B |
| 287 | 15-Jun-2021 | EHF is essential for epidermal and colonic epithelial homeostasis, and suppresses Apc-initiated colonic tumorigenesis. | Reehorst, Camilla M; Nightingale, Rebecca; Luk, Ian Y; Jenkins, Laura; Koentgen, Frank; Williams, David S ; Darido, Charbel; Tan, Fiona; Anderton, Holly; Chopin, Michael; Schoffer, Kael; Eissmann, Moritz F ; Buchert, Michael; Mouradov, Dmitri; Sieber, Oliver M; Ernst, Matthias ; Dhillon, Amardeep S; Mariadason, John M |
| 288 | 23-Aug-2021 | Elevated levels of circulating mitochondrial DNA predict early allograft dysfunction in patients following liver transplantation. | Yoshino, Osamu ; Wong, Boris Ka Leong; Cox, Daniel R A ; Lee, Eunice ; Hepworth, Graham; Christophi, Christopher ; Jones, Robert M ; Dobrovic, Alexander ; Muralidharan, Vijayaragavan ; Perini, Marcos V |
| 289 | 30-Aug-2018 | ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer. | Luk, Ian Y; Reehorst, Camilla M; Mariadason, John M |
| 290 | 5-Feb-2021 | ELOVL5 is a critical and targetable fatty acid elongase in prostate cancer. | Centenera, Margaret M; Scott, Julia S; Machiels, Jelle; Nassar, Zeyad D; Miller, Deanna C; Zininos, Irene; Dehairs, Jonas; Burvenich, Ingrid J G; Zadra, Giorgia; Chetta, Paolo; Bango, Clyde; Evergren, Emma; Ryan, Natalie K; Gillis, Joanna L; Mah, Chui Yan; Tieu, Terence; Hanson, Adrienne R; Carelli, Ryan; Bloch, Katarzyna; Panagopoulos, Vasilios; Waelkens, Etienne; Derua, Rita; Williams, Elizabeth D; Evdokioou, Andreas; Cifuentes-Rius, Anna; Voelcker, Nicolas H; Mills, Ian G; Tilley, Wayne D; Scott, Andrew M ; Loda, Massimo; Selth, Luke A; Swinnen, Johannes V; Butler, Lisa M |
| 291 | 16-Feb-2015 | Embryonic Chicken Transplantation is a Promising Model for Studying the Invasive Behavior of Melanoma Cells. | Jayachandran, Aparna; McKeown, Sonja J; Woods, Briannyn L; Prithviraj, Prashanth; Cebon, Jonathan S |
| 292 | Oct-2015 | Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer. | Johnstone, Cameron N ; Chand, Ashwini; Putoczki, Tracy L; Ernst, Matthias |
| 293 | 13-Apr-2023 | The emerging roles of autophagy in intestinal epithelial cells and its links to inflammatory bowel disease. | Tran, Sharon; Juliani, Juliani; Fairlie, Walter Douglas ; Lee, Erinna F |
| 294 | 28-Mar-2005 | Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR. | Panousis, C; Rayzman, V M; Johns, T G; Renner, C; Liu, Z; Cartwright, Glenn A; Lee, Fook-Thean; Wang, D; Gan, Hui K ; Cao, D; Kypridis, A; Smyth, Fiona E; Brechbiel, Martin W; Burgess, Antony W; Old, Lloyd J; Scott, Andrew M |
| 295 | 1-Apr-2006 | Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model. | Kelly, Marcus P; Lee, Fook-Thean; Smyth, Fiona E; Brechbiel, Martin W; Scott, Andrew M |
| 296 | 1-Oct-2005 | Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478. | Lee, Fook-Thean; Mountain, Angela J; Kelly, Marcus P; Hall, Cathrine; Rigopoulos, Angela; Johns, Terrance G; Smyth, Fiona E; Brechbiel, Martin W; Nice, Edouard C; Burgess, Antony W; Scott, Andrew M |
| 297 | 17-Dec-2018 | Enhanced Solubility, Permeability and Anticancer Activity of Vorinostat Using Tailored Mesoporous Silica Nanoparticles. | Meka, Anand Kumar; Jenkins, Laura J; Dàvalos-Salas, Mercedes; Pujara, Naisarg; Wong, Kuan Yau; Kumeria, Tushar; Mariadason, John M ; Popat, Amirali |
| 298 | 2022 | Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition. | Daly, Roger J; Scott, Andrew M ; Klein, Oliver ; Ernst, Matthias |
| 299 | Apr-2019 | Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2. | Barlesi, F; Drilon, A; De Braud, F; Cho, B C; Ahn, M J; Siena, S; Krebs, M G; Lin, C C; John, Thomas ; Tan, D S W; Seto, T; Dziadziuszko, R; Arkenau, H-T; Rolfo, C; Wolf, J; Ye, C; Riehl, T; Eng, S; Doebele, R C |
| 300 | Apr-2019 | Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001. | Paz-Ares, L; Doebele, R C; Farago, A F; Liu, S V; Chawla, S P; Tosi, D; Blakely, C M; Krauss, J C; Sigal, D; Bazhenova, L; John, Thomas ; Besse, B; Wolf, J; Seto, T; Chow-Maneval, E; Ye, C; Simmons, B; Demetri, G D |
